Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Integrated Sciences Inc (NQ: NVOS )

0.1490 UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novo Integrated Sciences Inc

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Novo Integrated Sciences to Participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest
From Novo Integrated Sciences, Inc. Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences’ IoNovo for Kids Pure Iodine Oral Spray Granted Natural Product Number (NPN) by Health Canada
From Novo Integrated Sciences, Inc.
Via Business Wire
Multidisciplinary Nasdaq Listed Healthcare Provider Growing via Multiple High Value Acquisitions: Novo Integrated Sciences, Inc. (NASDAQ: NVOS)
Via Viz Release
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Rani Therapeutics Hldgs (NASDAQ:RANI 
Via Benzinga
Novo Integrated Sciences Reports First Quarter Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Announces the Signing of a Master Facility License Agreement with LA Fitness in Canada
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Oncternal Therapeutics (NASDAQ:ONCT 
Via Benzinga
Novo Integrated Sciences Granted Natural Product Number (NPN) by Health Canada for IoNovo Iodine Branded Product
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Reports Fiscal Full Year 2021 Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Acquires Majority Stake in Terragenx
Novo Integrated Sciences Inc (NASDAQ: NVOS) has acquired 91% of Terragenx through an all-share transaction at $3.35 per share. The human immune system... 
Via Benzinga
Novo Integrated Sciences Acquires Majority Stake in Terragenx and Intellectual Property for FDA and Health Canada Approved Water-Soluble Iodine Micro-Nutrient
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 95.32% to $9.61 during Monday's regular session. Trading volume for iSpecimen's stock is 70.9 million as of... 
Via Benzinga
Novo Integrated Sciences (NASDAQ: NVOS) Just Announced a Partnership That Could Shake Up the Telehealth Sector
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Novo Integrated... 
Via Benzinga
Novo Integrated Sciences’ subsidiary, Novo Healthnet Limited, and EK-Tech Solutions Announce Joint Venture for Enhanced Telehealth Platform
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Signs LOIs to Acquire 7 Pharmacies in the US
Image provided by Tbel Abuseridze on Unsplash Novo Integrated Sciences, Inc. (NASDAQ: NVOS), a pioneer in holistic, patient-first health and wellness services and products, has... 
Via Benzinga
Multidisciplinary Nasdaq Listed Healthcare Provider Growing via Multiple High Value Acquisitions: Novo Integrated Sciences, Inc. (NASDAQ: NVOS)
Via Get News
22 Stocks Moving in Friday's Pre-Market Session
Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 42% to $15.24 in pre-market trading. The company’s shares jumped around 65% over the previous month. vTv Therapeutics Inc... 
Via Benzinga
Novo Integrated Sciences to Present at the Benzinga Virtual Global Healthcare Small Cap Conference on September 30th
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Larimar Therapeutics (NASDAQ: 
Via Benzinga
Novo Integrated Sciences Signs LOIs to Acquire Seven Pharmacies in the United States
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Cara Therapeutics (NASDAQ:CARA) ... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers PharmaCyte Biotech (NASDAQ:PMCB) shares rose 71.92% to $5.88 during Wednesday's pre-market session. The market value of their outstanding shares is at $9.4... 
Via Benzinga
Novo Integrated Sciences’ Subsidiary, Acenzia, Signs Exclusive Licensing Agreement with Performance Inspired Nutrition to Manufacture and Distribute in the Middle East
From Novo Integrated Sciences, Inc.
Via Business Wire
Novo Integrated Sciences Launches New Patient Portal App Giving Patients More Control Over Their Healthcare
The ‘new’ reality of the COVID-19 pandemic, ongoing advancements in medical technology, inter-connectivity, and blockchain technology, are all key drivers in the... 
Via Benzinga
Exposures COVID-19
60 Biggest Movers From Yesterday
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 33.7% to close at $3.37 on Monday after the company announced plan to expand product portfolio with introduction of... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Nuwellis (NASDAQ:NUWE) shares in... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Akebia Therapeutics (NASDAQ:AKBA... 
Via Benzinga
Novo Integrated Sciences' Patented Zgraft Platform can Predict Cancer Progression and Treatment Outcomes
Image Provided By Pexels Novo Integrated Sciences Inc. (NASDAQ: NVOS), a pioneer in developing patient-centric care through advanced therapeutics and technology, recently acquired... 
Via Benzinga
Novo Integrated Sciences Announces Third Quarter 2021 Financial Results
From Novo Integrated Sciences, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Celldex Therapeutics (NASDAQ:CLDX) stock rose 41.93% to $46.0 during Monday's pre-market session. The company's market cap stands at $1.8 billion. 180 Life... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.